Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$195M
| $3.25M | ﹤0.01% |
112,412
-239,828
| -68% | -$6.85M |
|
2377
Element Solutions
ESI
$9.46B
| $3.25M | ﹤0.01% |
169,319
-27,854
| -14% | -$512K |
|
2378
RLI Corp
RLI
$5.85B
| $3.25M | ﹤0.01% |
47,586
+994
| +2% | +$66.1K |
|
2379
PENN Entertainment
PENN
$2.52B
| $3.24M | ﹤0.01% |
134,707
+63,124
| +88% | +$1.68M |
|
2380
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
| $3.23M | ﹤0.01% |
40,852
-2,989
| -7% | -$237K |
|
2381
iShares MSCI Singapore ETF
EWS
$1.17B
| $3.23M | ﹤0.01% |
174,366
-5,360
| -3% | -$104K |
|
2382
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.1B
| $3.23M | ﹤0.01% |
57,230
-3,996
| -7% | -$198K |
|
2383
Sprout Social
SPT
$599M
| $3.22M | ﹤0.01% |
69,802
-218
| -0.3% | -$10.4K |
|
2384
DigitalBridge
DBRG
$2.94B
| $3.22M | ﹤0.01% |
218,551
+48,673
| +29% | +$597K |
|
2385
iShares Emerging Markets Equity Factor ETF
EMGF
$1.91B
| $3.21M | ﹤0.01% |
77,095
-17,116
| -18% | -$706K |
|
2386
Maximus
MMS
$2.89B
| $3.2M | ﹤0.01% |
37,823
+14,874
| +65% | +$1.22M |
|
2387
iShares Morningstar Mid-Cap ETF
IMCB
$1.73B
| $3.18M | ﹤0.01% |
50,219
+689
| +1% | +$41.5K |
|
|
FOLD
2388
DELISTED
Amicus Therapeutics
FOLD
| $3.17M | ﹤0.01% |
252,174
-12,028
| -5% | -$143K |
|
|
MSD
2389
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
| $3.17M | ﹤0.01% |
492,005
+37,000
| +8% | +$241K |
|
|
SEM
2390
DELISTED
Select Medical
SEM
| $3.17M | ﹤0.01% |
184,459
-10,872
| -6% | -$168K |
|
2391
APi Group
APG
$19B
| $3.16M | ﹤0.01% |
173,900
-59,250
| -25% | -$917K |
|
2392
Omega Healthcare
OHI
$14.1B
| $3.16M | ﹤0.01% |
102,976
-24,727
| -19% | -$714K |
|
2393
Schwab Fundamental US Small Company Index ETF
FNDA
$9.45B
| $3.16M | ﹤0.01% |
125,282
-638
| -0.5% | -$15.3K |
|
2394
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$418M
| $3.15M | ﹤0.01% |
103,550
+73,725
| +247% | +$2.25M |
|
2395
CALL
OR Royalties Inc
OR
$6.25B
| $3.15M | ﹤0.01% |
205,300
+100,000
| +95% | +$1.62M |
|
2396
AbCellera Biologics
ABCL
$3.49B
| $3.15M | ﹤0.01% |
487,845
-663,416
| -58% | -$4.53M |
|
2397
SLR Investment Corp
SLRC
$703M
| $3.15M | ﹤0.01% |
220,806
-5,371
| -2% | -$76.9K |
|
|
ERC
2398
Allspring Multi-Sector Income Fund
ERC
$261M
| $3.15M | ﹤0.01% |
339,990
+120,409
| +55% | +$1.08M |
|
2399
Energizer
ENR
$1.56B
| $3.15M | ﹤0.01% |
93,680
-1,595
| -2% | -$53.3K |
|
2400
Omeros
OMER
$1.24B
| $3.14M | ﹤0.01% |
577,732
+2,000
| +0.3% | +$11.7K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.